The Big Story
-
The Big Story
Riffing On Tariff Tiffs And Risks As Uncertainty Reigns
The Trump tariff situation is in constant flux, creating uncertainty that spells doom for any potential growth in US ad spending this year. Plus, how retail media and other emerging channels could be threatened by tariff turmoil.
-
The Big Story
Bots And Games Are Back (For Ad Tech)
What’s old is new. Time is a flat circle. Trends are cyclical. Choose your idiom, because this week’s episode grapples with two topics that are not new to online advertising, but have both roared back into the public consciousness. The first is the scourge of bot traffic, scrutiny courtesy of a recent Adalytics report, and […]
-
The Big Story
In The Room Where (The Ad Auction) Happens
The IAB Tech Lab is proposing that ad auctions move to a Trusted Server from the browser. Why its prototype attracted controversy. Plus, should data privacy be viewed as a badge of honor, or a baseline standard?
-
The Big Story
M&A Mania: The Latest On Oracle-TikTok, and the Alphonso-LG Ads Aftermath
Alphonso shareholders won their lawsuit against LG Ads, clearing the way for an IPO. Then, as TikTok counts down the days until its stay of execution expires, Oracle might buy a minority stake.
-
The Big Story
Tariff Chaos And Yet More Ad Tech M&A
Tariffs are taking effect in the US, and advertisers are shook. Our special guest, Madison and Wall’s Brian Wieser, weighs in on the “blindingly obvious” consequences of implementing tariffs, including supply-chain disruptions that lead to a pullback in ad spend. You can’t promote what you can’t produce. Plus: the rationale behind Publicis’ acquisition of Lotame.
-
The Big Story
Programmatic’s Pursuit of “Premium”
Programmatic algorithms optimize for performance, which can leave digital media companies floundering. Inside programmatic’s pursuit of “premium.” Plus: an ad tech acquisition forged on matchmaking buy-side and sell-side IDs.
-
The Big Story
Connected TV’s Growth Spurt; How Ozempic Is Upending Marketing
In her last week at AdExchanger, Senior Editor Alyssa Boyle reflects on three years of change, and stasis, in the CTV space. Then, how Ozempic is changing the marketing world.
-
The Big Story
The Trade Desk Miss That Shook Ad Tech
When The Trade Desk, the ad tech darling of Wall Street, missed its earnings forecast for the first time, ad tech insiders paid attention. Plus: Reddit, fueled by Google Search, sputters after an algorithmic adjustment.
-
The Big Story
The Worst Place To Show An Ad
When an ad shows up next to illegal content, there is often not a single point of failure. Adalytics Krzysztof Franaszek walks us through why he found ads showing up next to the worst kind of criminal content — and the simple and complex solutions to this problem.
-
The Big Story
Chrome’s Global Cookie Consent, and Nielsen and Paramount Make Nice
The Google Chrome team is getting closer to deciding on its cookie consent mechanism. And Paramount resolves its four-month standoff with Nielsen, as the mechanics behind currency change forever.